规划适应性平台试验的关键考虑:第1部分
Anders Granholm1, Morten Hylander Møller2, Aldana Rosso3
1Department of Intensive Care, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Section of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark; Platform Trial Unit, Value and Coherence, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.
Journal of clinical epidemiology
|March 9, 2026
概括
适应性平台试验 (APT) 在临床研究中提供了灵活性和效率,但计划起来很复杂. 本指南为设计这些复杂的随机临床试验的研究人员提供了必要的考虑因素.
科学领域:
- 临床试验方法论 临床试验方法论
- 适应性试验设计
背景情况:
- 对复杂临床研究的适应性平台试验 (APT) 越来越感兴趣.
- 与传统试验相比,APT提供了更高的灵活性,效率和成本效益.
- 目前对于计划APT的指导是有限的.
研究的目的:
- 为适应性平台试验提供关键规划考虑因素的叙事概述.
- 提供基于APT启动的实践经验的指导.
主要方法:
- 这是一个分为两部分的系列,详细介绍了APT的基本规划方面.
- 专注于对关键考虑的叙事概述.
主要成果:
- 第一部分涵盖了利益相关者的参与,人口,干预,结果和适应.
- 第二部分将讨论统计,设计特征,数据,操作,资金,传播和实施.
结论:
- 本指南旨在协助研究人员规划适应性平台试验.
- 提出了关键考虑因素,以促进APT的成功设计和启动.
相关概念视频
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...


